社论：“囊性纤维化治疗方法”特刊
Editorial: Special Issue on "Therapeutic Approaches for Cystic Fibrosis".
机构信息
UOC Genetica Medica, IRCCS Giannina Gaslini, 16147 Genova, Italy.
出版信息
Int J Mol Sci. 2020 Sep 11;21(18):6657. doi: 10.3390/ijms21186657.
Abstract
Cystic fibrosis (CF) is the most common lethal genetic disease in Caucasian populations, occurring in approximately 1 in 3000 newborns worldwide [...].
摘要
囊性纤维化（CF）是白种人群中最常见的致命性遗传疾病，全球约每 3000 名新生儿中就有 1 名患有该病[... ]。
相似文献
1
Editorial: Special Issue on "Therapeutic Approaches for Cystic Fibrosis".
Int J Mol Sci. 2020 Sep 11;21(18):6657. doi: 10.3390/ijms21186657.
2
Unique mutations of the cystic fibrosis transmembrane conductance regulator gene of three cases of cystic fibrosis in Nagasaki, Japan.
Intern Med. 2009;48(15):1327-31. doi: 10.2169/internalmedicine.48.2078. Epub 2009 Aug 3.
3
Pharmacogenetics of cystic fibrosis treatment.
Pharmacogenomics. 2016 Aug;17(13):1453-63. doi: 10.2217/pgs.16.25. Epub 2016 Aug 4.
4
Distribution of CFTR mutations in cystic fibrosis patients of Tunisian origin: identification of two novel mutations.
Eur J Hum Genet. 1996;4(1):20-4. doi: 10.1159/000472165.
5
[Cystic fibrosis: relationship between genotype and phenotype].
Arch Pediatr. 2003 Sep;10 Suppl 2:318s-324s. doi: 10.1016/s0929-693x(03)90046-7.
6
Clinical implications of cystic fibrosis transmembrane conductance regulator mutations.
Clin Chest Med. 1998 Sep;19(3):443-58, v. doi: 10.1016/s0272-5231(05)70092-7.
7
Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
J Gene Med. 2013 Nov-Dec;15(11-12):414-26. doi: 10.1002/jgm.2748.
8
[Modifier genes and cystic fibrosis].
Arch Pediatr. 2006 Jan;13(1):57-63. doi: 10.1016/j.arcped.2005.09.029. Epub 2005 Nov 7.
9
Molecular Genetics of Cystic Fibrosis Transmembrane Conductance Regulator: Genotype and Phenotype.
Pediatr Clin North Am. 2016 Aug;63(4):585-98. doi: 10.1016/j.pcl.2016.04.002.
10
Sweat chloride and immunoreactive trypsinogen in infants carrying two mutations and not affected by cystic fibrosis.
Arch Dis Child. 2017 Jul;102(7):644-646. doi: 10.1136/archdischild-2015-309348. Epub 2016 Jan 11.
本文引用的文献
1
From Ivacaftor to Triple Combination: A Systematic Review of Efficacy and Safety of CFTR Modulators in People with Cystic Fibrosis.
Int J Mol Sci. 2020 Aug 16;21(16):5882. doi: 10.3390/ijms21165882.
2
Phosphorylation of the Chaperone-Like HspB5 Rescues Trafficking and Function of F508del-CFTR.
Int J Mol Sci. 2020 Jul 8;21(14):4844. doi: 10.3390/ijms21144844.
3
GM1 as Adjuvant of Innovative Therapies for Cystic Fibrosis Disease.
Int J Mol Sci. 2020 Jun 24;21(12):4486. doi: 10.3390/ijms21124486.
4
The Effect of Sodium Bicarbonate, a Beneficial Adjuvant Molecule in Cystic Fibrosis, on Bronchial Epithelial Cells Expressing a Wild-Type or Mutant CFTR Channel.
Int J Mol Sci. 2020 Jun 4;21(11):4024. doi: 10.3390/ijms21114024.
5
Gene Therapy for Cystic Fibrosis: Progress and Challenges of Genome Editing.
Int J Mol Sci. 2020 May 30;21(11):3903. doi: 10.3390/ijms21113903.
6
The Role of MicroRNA in the Airway Surface Liquid Homeostasis.
Int J Mol Sci. 2020 May 28;21(11):3848. doi: 10.3390/ijms21113848.
7
Synthesis and Therapeutic Applications of Iminosugars in Cystic Fibrosis.
Int J Mol Sci. 2020 May 9;21(9):3353. doi: 10.3390/ijms21093353.
8
Immunomodulation in Cystic Fibrosis: Why and How?
Int J Mol Sci. 2020 May 8;21(9):3331. doi: 10.3390/ijms21093331.
9
What Role Does CFTR Play in Development, Differentiation, Regeneration and Cancer?
Int J Mol Sci. 2020 Apr 29;21(9):3133. doi: 10.3390/ijms21093133.
10
Mechanical Properties of Human Bronchial Epithelial Cells Expressing Wt- and Mutant CFTR.
Int J Mol Sci. 2020 Apr 21;21(8):2916. doi: 10.3390/ijms21082916.
Zotero 插件